Ratings by Clear Street
| Date | Analyst | Company | Symbol | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|---|
| 6/10/2026 | Kaveri Pohlman | Cullinan Oncology Inc. | CGEM | Maintain | Buy (N/A) |
46.00 (33.00) |
|
Details | |
| 6/2/2026 | N/A | Amprius Technologies | AMPX | New Coverage | Buy (N/A) |
33.00 (N/A) |
21.75 (16.31) |
-25.01% | Details |
![]() |
|||||||||
![]() |
|||||||||
![]() |
|||||||||
![]() |
|||||||||
![]() |
|||||||||
![]() |
|||||||||
![]() |
|||||||||
![]() |
|||||||||
| 209 more... | |||||||||


